TFA Therapeutics annual net debt
2021
2022
2023
2024
2025
TFA Therapeutics Net Debt Growth & History (RAJAF)
TFA Therapeutics's net debt was $9,974 for fiscal 2025.
View full TFA Therapeutics company overviewTFA Therapeutics annual net debt history
| Fiscal year | Period ended | Net debt | Change | Growth |
|---|---|---|---|---|
| 2025 | 2025-12-31 | $9,974 | −$52,360 | −84.00% |
| 2024 | 2024-12-31 | $62,334 | −$542,088 | −89.69% |
| 2023 | 2023-12-31 | $604,422 | −$38,225 | −5.95% |
| 2022 | 2022-12-31 | $642,647 | $472,769 | +278.30% |
| 2021 | 2021-12-31 | $169,878 | — | — |
TFA Therapeutics quarterly net debt
Q4.21
Q4.22
Q3.23
Q4.23
Q4.24
Q4.25
| Fiscal quarter | Period ended | Net debt | Change | YoY change |
|---|---|---|---|---|
| Q4 2025 | 2025-12-31 | $9,974 | −$52,360 | −84.00% |
| Q4 2024 | 2024-12-31 | $62,334 | −$542,088 | −89.69% |
| Q4 2023 | 2023-12-31 | $604,422 | −$38,225 | −5.95% |
| Q3 2023 | 2023-09-30 | $284,802 | — | — |
| Q4 2022 | 2022-12-31 | $642,647 | $472,769 | +278.30% |
| Q4 2021 | 2021-12-31 | $169,878 | — | — |
TFA Therapeutics net debt trends
Between the periods ended 2021-12-31 and 2025-12-31, TFA Therapeutics's net debt decreased from $169,878 to $9,974, a change of −$159,904. The latest reported quarter, Q4 2025, shows $9,974.
About the metric
What net debt means
Net debt compares a company’s interest-bearing debt with its cash and cash equivalents. Positive net debt means debt exceeds cash, while a negative value indicates the company has more cash than debt on this measure.
Calculation and source
How net debt is calculated
TickerStat calculates net debt as total interest-bearing debt minus cash and cash equivalents at the same reporting-period end. Short-term investments are not subtracted because they are not included in the standardized cash series. Fiscal periods can differ from calendar years, so exact period-end dates are included.
Review TFA Therapeutics source filings ↗